BioPharma Resources

Drug Trial Radar · NCT07902817

A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of JADE101 Administered Subcutaneously in Participants With Immunoglobulin A Nephropathy (The EVERGREEN Study)

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

480

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Jun 2029

Study completion Sep 2030

Sponsor

Lead sponsor
Jade Biosciences, Inc.Industry
Sponsor type
Industry
First posted
Oct 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 3 study will evaluate the safety and efficacy of JADE101 compared with placebo in adults with immunoglobulin A nephropathy (IgAN). The results will contribute to the overall clinical characterization of JADE101 in this patient population.

Conditions

  • IgA Nephropathy (IgAN)

Interventions

  • JADE101Drug

    JADE101 is supplied as sterile solution to be administered by SC injection.

  • PlaceboDrug

    Placebo is supplied as sterile solution to be administered by SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the effect of JADE101 on Urine Protein Creatinine Ratio (UPCR) in participants with IgA nephropathyTime frame: Week 52

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Jade Clinical Site

    Arvada, Colorado · Recruiting

  • Jade Clinical Site

    Lauderdale Lakes, Florida · Recruiting

  • Jade Clinical Site

    Atlanta, Georgia · Recruiting

  • Jade Clinical Site

    Katy, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.